Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
Coagulation
Interventions
DEVICE

Whole Blood Clotting Time

"Fresh whole blood samples from patients on rivaroxaban or apixaban taken at various times during the day to obtain samples from DOAC patients that represent the entire analytical range to the extent possible, as opposed to a strict trough/peak testing schedule."

DEVICE

Whole Blood Clotting Time

Fresh whole blood samples, non-citrated, are drawn and loaded onto a cuvette free of any biological reagents, to obtain a whole blood clotting time value.

Trial Locations (4)

13326

RECRUITING

Bassett Research Institute - Center for Clinical Research, Cooperstown

20850

RECRUITING

Perosphere Technologies Inc, Rockville

06811

RECRUITING

Perosphere Technologies Inc, Danbury

07834

RECRUITING

Eastern Vascular Associates, Denville

Sponsors
All Listed Sponsors
lead

Perosphere Technologies Inc.

INDUSTRY

NCT07012291 - Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™ | Biotech Hunter | Biotech Hunter